Critically Ill Patients | ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

Critically Ill Patients research study

What is the primary objective of this study?

ICG- Leberfunktionstest versus \"neue\" Biomarker als prognostischer Marker bei intensivmedizischen Patienten

Who is eligible to participate?

Inclusion criteria: Gruppe 1: - Intensiv-Patienten mit Verbrennungen > 10% der Körperoberfläche - Alter > 18 Gruppe 2: - Intensivpatienten nach grossen chirurgischen Eingriffen - Alter > 18 Gruppe 3: - Polytraumatisierte, intensivpflichtige Patienten - Alter > 18 Exclusion criteria: • Alter < 18 - Schwangerschaft - Einschluss in eine andere Studie - Moribunde Patienten - Patienten, die kein Deutsch verstehen - Jodunverträglichkeit

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Critically Ill Patients

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Procedure:ObservationalBlood draw

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

ICU patientsAdmitted patients to the ICU

Study Status

Unknown status

Start Date: May 2010

Completed Date: May 2011


Type: Observational


Primary Outcome:

Secondary Outcome:

Study sponsors, principal investigator, and references

Principal Investigator: 01 Studienregister MasterAdmins

Lead Sponsor: University of Zurich

Collaborator: Intuitive Surgical

More information:

Discuss Malaise